Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy

摘要

Objective Intravenous (iv) glucocorticoids (GC) (ivGC) and orbital radiotherapy (ORT) are commonly used in active Graves' orbitopathy (GO), with favorable outcomes in up to 80 of patients. However, little is known on the factors that may affect GO outcome in the long term, an issue that we investigated here.